Pub­li­ca­tions

News Articles

1. Publications, Kanvas Bio

   07, Nov, 2025

   KAN-004, a Meta­bol­i­cal­ly Com­plete Live Bio­ther­a­peu­tic Prod­uct for the Treat­ment of Immune-Relat­ed Colitis

2. Publications, Kanvas Bio

   07, Nov, 2025

   KAN-001, a Defined Live Bio­ther­a­peu­tic Prod­uct (LBP) for NSCLC, Enhances ICI Response in Pre­clin­i­cal Mod­els and Demon­strates Man­u­fac­tur­ing Con­sis­ten­cy and Strain-Resolved Viability

3. Publications, Kanvas Bio

   07, Nov, 2024

   The gut micro­bio­me enhances anti-PD‑1 effi­ca­cy in a tumor-agnos­tic man­ner: results from a phase II tri­al of fecal micro­bio­ta trans­plan­ta­tion and anti-PD‑1 re-induc­tion in MSI‑H refrac­to­ry cancers